Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 8,506,000 | 8,295,000 | 8,244,000 | 7,594,000 | 7,314,000 |
| Cost of Goods | 1,062,000 | 1,064,000 | 998,000 | 882,000 | 1,063,000 |
| Gross Profit | 7,444,000 | 7,231,000 | 7,246,000 | 6,712,000 | 6,251,000 |
| Operating Expenses | 1,823,000 | 1,646,000 | 1,630,000 | 1,341,000 | 1,921,000 |
| Operating Income | 5,621,000 | 5,585,000 | 5,616,000 | 5,371,000 | 4,330,000 |
| Interest Expense | 230,000 | 165,000 | 140,000 | 153,000 | 130,000 |
| Other Income | 46,000 | 52,000 | 35,000 | 21,000 | 30,000 |
| Pre-tax Income | 5,437,000 | 5,472,000 | 5,511,000 | 5,239,000 | 4,230,000 |
| Income Tax | 752,000 | 880,000 | 1,014,000 | 907,000 | 768,000 |
| Net Income Continuous | 4,685,000 | 4,592,000 | 4,497,000 | 4,332,000 | 3,462,000 |
| Minority Interests | 2,000 | -8,000 | 5,000 | -1,000 | -25,000 |
| Net Income | $4,683,000 | $4,600,000 | $4,492,000 | $4,333,000 | $3,487,000 |
| EPS Basic Total Ops | 3.27 | 3.14 | 3.05 | 2.91 | 2.31 |
| EPS Basic Continuous Ops | 3.26 | 3.14 | 3.06 | 2.91 | 2.30 |
| EPS Diluted Total Ops | 3.17 | 3.06 | 2.92 | 2.76 | 2.15 |
| EPS Diluted Continuous Ops | 3.17 | 3.06 | 2.92 | 2.76 | 2.14 |
| EBITDA(a) | $5,899,000 | $5,863,000 | $5,889,000 | $5,640,000 | $4,605,000 |